Overexpression of aminopeptidase A abolishes the growth promoting effects of angiotensin II in cultured mouse mesangial cells. Angiotensin II (Ang II) has diverse effects on the glomerular tuft such as regulation of glomerular hemodynamics and stimulation of mesangial cell growth, and may be one pivotal factor in the progression of renal disease. In order to locally inactivate Ang II, we overexpressed aminopeptidase A (E.C. 3.4.11.7; AT A), a peptidase involved in the conversion of Ang II into angiotensin III, in a mouse mesangial cell line (MMC) that normally does not exhibit this enzyme. Stable transfections were selected in medium containing G418. ATA-overexpressing clones ATA5 and ATA21 revealed mRNA, protein, and enzyme activity in contrast to wild-type MMCs or mock-transfected Neo3 cells (stably transfected with expression vectors without ATA cDNA). There was no difference in the binding of Ang II to its putative receptors in all cell lines. Ang II increased intracellular inositol 1,4,5-triphosphate (IP3) in Neo3, but not in ATA5 and ATA21 cells. In contrast to MMCs and Neo3 cells, Ang II failed to stimulate proliferation in ATA5 and ATA21 clones as measured by [3H] thymidine incorporation and direct cell counts. However, ATA5 and ATA21 revealed a mitogenic response not different from MMCs after stimulation 2% or 10% of fetal calf serum. Treatment of ATA5 and ATA21 with 0.1 mM of the ATAinhibitor ainastatin or an ATA-inhibiting specific monoclonal antibody restored the proliferative effect of Ang II, suggesting that surface activity of ATA is involved in the attenuated mitogenesis in these cell. Our study demonstrates that it is feasible to overexpress Ang II-degrading enzymes in cultured mesangial cells and that this overexpression attenuated some effect of exogenous Ang II. These experiments are a first step toward the development of novel strategies to selectively antagonize locally generated Ang II in the kidney.
© 1997 by the International Society of Nephrology the glomerular tuft [1] [2] [3] [4] [5] [6] [7] . The most direct proof of the detrimental actions of Ang II on the glomerulus may stem from investigations in rats that overexpress angiotensinogen and renin in the glomer ulus [9] . These animals developed irreversible glomerulosclerosis without hypertension, suggesting that Ang II growth promoting effects may play a pivotal role in these structural alterations [9] , Although several substances, including angiotensin converting enzyme (ACE) inhibitors as well as the new non-peptide Ang Il-receptor antagonists, could effectively interfere with Ang II's action, there is recent evidence of an independent renal reninangiotensin system (RAS) that may not be necessarily inhibited by the commonly used concentrations of these drugs [3, 7] .
In the present study, we have applied a different approach to locally inactivate Ang II. Cultured murine mesangial cells (MMC) were stably transfected with an expression plasmid in order to overexpress aminopeptidase A (E.C. 3.4.11.7; ATA). ATA is an Ang II degrading enzyme and is normally expressed in the kidney in mouse podocytes as well as proximal tubular epithelia cells, but not in mesangial cells [10] . The overexpression of ATA in MMCs abolished the mitogenic action of Ang II normally observed in these cells, but was without effect on Ang II-receptor expression or proliferative response induced by other mitogens. Our studies demonstrate that it is feasible to overexpress an Ang II-splitting enzyme to antagonize the actions of this vasopeptide presumably by its faster degradation.
METHODS

Cell culture
Mouse mesangial cells (MMCs) are a SV 40-transformed cell line originally isolated from 8-to 10-week-old naive SJL/J (H-2h) mice [11] . These cells possess many features of differentiated mesangial cells including expression of Ang II-receptors and a Fc-receptor for immunoglobulins, and have been extensively characterized [11] [12] [13] [14] . MMCs were grown in Dulbecco's Modified Eagle's medium (DMEM; Gibco-BRL, Eggenstein, Germany) containing 450 mg/dl glucose, 100 U/ml penicillin, 100 fxg/ml streptomycin, 5 mM glutamine, and 10% decomplemented fetal calf serum (FCS; Gibco-BRL). Cells were grown in 5% C 0 2 afld passaged every 48 to 72 hours by trypsinization.
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Transfection procedures and selection of ATA overexp res sing clones
For ATA overexpression, 106 MMCs were cotransfected with 10 /xg of each SRaBP-1 (gift of Max D. Cooper, University of Alabama, Birmingham, AL, USA) [15] and 5 ¡jlg pHook-1 (Invitrogen, Leek, Netherlands) using calcium phosphate. The SRaBP-l plasmid contains a full-length cDNA encoding for BP-1, the mouse ATA, driven by the SRa promoter that is composed of the SV 40 early promoter and the R segment, and is part of the U5 sequence of the long terminal repeat of human T-cell leukemia virus type I [16] . The SRaBP-1 construct has been previously used to express ATA in COS-7 and Ltk~ cells [15] . Besides a neomycin resistance, the pHook-1 plasmid expresses a single-chain antibody (sFv) to a specific hapten (see below) being displayed on the surface of transfected cells. Twenty-four hours after transfection, cells were released from the plate by light trypsinization, washed, and were collected in a 1.5 ml cup. Cells were mixed with 1.5 x 10fi magnetic beads bearing the phOx (4-rthoxy-methylene-2phenyl-2-oxazolin-5-one) hapten on their surface (Capture beads; Invitrogen). After incubation with slow rotation (5 revolutions per min) for 30 minutes at 37°C, the beads were pelleted with a magnetic stand' (Invitrogen). Non-selected cells were removed, pellets were washed in serum-free DMEM, and the pelleting was repeated with the magnetic stand. This washing step was repeated twice. Finally, cells were plated at low-density into a 96-well plate in DMEM with 10% FCS. After another 24 hours, the medium was changed and 600 fig/ml of G418 (Gibco-BRL) were added to select for stable transfectants. In pilot experiments we established that this concentration of G418 was toxic for wild-type MMCs. After one week, surviving cells were cloned by limiting dilution and replated in 96-well plates in the presence of G418. Estab lished cultures were maintained in medium with 600 jug/ml G418 to prevent back mutations. In general, no G418 was used for proliferation experiments and enzyme measurements.
In addition, control cell lines were established by transfecting MMCs with an SRa vector [16] without a BP-1 insert and the pHook-1 plasmid. Selection of sFV bearing cells and limiting dilution in G418 containing medium was performed as described above. Control cell lines were designated as Neo.
RT-PCR for aminopeptidase A and Northern blotting
Stable transfectants were initially screened for ATA transcripts by cDNA amplification of reverse transcribed total RNA. There fore, a total of 106 cells were lysed in 5 ml of a buffer containing 4 m guanidine thiocyanate, 25 m M sodium citrate (pH 7.0), 0.5% sodium lauroyl-sarcosinate, and 0.7% /3-mercaptoethanol. Total RNA was extracted by repetitive phenol-chloroform extraction and was precipitated with ice-cold isopropranolol [12] . For re verse transcription, 5 fig of total RNA in 7.5 ¡A water were incubated at 65°C for three minutes, and subsequently 5. were added, and the reaction was incubated at 37°C for 90 minutes. After first-strand cDNA synthesis, the reaction mix was precipitated with 7.5 m ammonium acetate and isopropanol. The pellets were washed in 70% ethanol and resuspended in 50 rd water. Five microiiters of each cDNA and 150 ng of the following primers were used: mouse ATA, 5'GACGTACTTTC-AAGGCCAAGTG35'GCTGCAGTTCAGTGTTGAAGGG3' [17] ; GAPDH, 5' A AT G CAT CCT GC ACC AC CA A3', 5'GTAGC-CATATTCATTGTCATA3' [18] . The predicted sizes of the amplification reactions were 563 bp for ATA, and 521 bp for GAPDH. Amplification reactions were performed exactly as described previously [19] with 0.2 m of each dNTP and 2.5 U of Taq polymerase (Perkin Elmer Cetus, Ueberlingen, Germany) in amplification buffer (20 mM Tris-HCl, pH 8.3; 25 mM KC1, 2.0 mM MgCl2, 0.05% Tween 20). Amplifications for mouse ATA and GAPDH was performed in separate tubes. Thirty-five cycles with a denaturation step for 92°C for one minute, an annealing step of 56°C for 1.5 minutes, and an extension step at 72°C for 1.5 minutes were performed. Ten microiiters of each reaction product were run on a 1.5% agarose gel containing 0.5 ¿¿g/ml ethidium bromide.
To confirm the results obtained from RT-PCR by Northern blotting, 20 jug of total RNA was electrophoresed through a 1.2% agarose gel with 2.2 M formaldehyde. The RNA was vacuum blotted onto a nylon membrane (Zetabind; Cuno, Meriden, CT, USA) and UV cross-linked. For the detection of mouse ATA transcripts, a 3.5 kilobase fragment of the cDNA BP-1 (also a gift of Max D. Cooper) [17] was labeled using random primers. For control hybridization after stripping, a 2.0 kilobase insert of the plasmid pMCl encoding the mouse 18S RNA band was used. Hybridization, washing, and stripping procedures were performed exactly as previously described [12, 13] ,
Angiotensin II-receptor expression
To test whether ATA overexpressing cells may exhibit a differ ent expression pattern of Ang II-receptors, RT-PCR for the ATr receptor as well as competition binding studies were per formed, RT-PCR was executed for 35 cycles a.s described above (same temperature profile) with the following primers for the AT l -receptor: 5' GAT A ATTATGGCG ATTGT G3' and 5'GTA-AGAAAGCGTGCTCATTTTCG3' [20] . The predicted size of the amplified product was 238 bp. Hybridization of an end labeled internal primer to the amplification product revealed the correct nature of the product (data not shown). For control reactions, the following primers for mouse j3-actin were used: 5'GGCCAAGT-CATCACTATTG G3' and 5' GGACTCATCGTACTCCTGC3'. Reactions were independently (RNA isolation, reverse transcrip tion, and cDNA amplification) performed four times with quali tatively similar results.
Binding studies were carried out on 5 X 104 cells grown to subconfluence in 24-well culture plates in assay buffer consisting of 150 mM NaCl, 5 mM MgCl2, 50 mM Tris-HCl (pH 7.1), 5 mM EDTA, 0.7% bovine serum albumin, 0.5% aprotinin, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 0.5 mM amastatin (Sigma, Deisenhofen, Germany) to inhibit potential ATA activity in overexpressing clones [21] , For displacement experiments, 0.5 pM [tyrosyl-3,5-3H]-angiotensin II (30 to 60 Ci/mmol; Amersham, Braunschweig, Germany) was incubated in the presence or ab sence of 10~9 to 10-7 m cold Ang II (Sigma) for two hours on a shaking platform at 22°C. At the end of the incubation period, cells were washed three times in ice-cold PBS, precipitated in 10% trichloracetic acid, and proteins were redissolved in 1 n NaOH. Radioactivity was determined by liquid scintillation spectroscopy. Nonspecific binding was determined in the presence of 10 ~5 m non-radioactive Ang II and was less than 10% of total binding. Specific binding in the absence of cold competitor was considered to be 100%. Experiments were repeated four times with duplicate measurements for each experiment.
Aminopeptidase A enzyme activity
Aminopeptidase A (ATA) surface enzyme activities were mea sured on subconfluent cells in 24-well plates rested for 24 hours in serum-free DMEM, For this reason, lO^ cells were incubated for one hour in 1 ml of a substrate solution containing 17,5 mM alpha-glutamyl-nitranilide (Serva, Heidelberg, Germany) in 0.5 m Tris-HCl (pH 7.2) supplemented with 10 mM calcium chloride. At the end of the incubation, cells were washed in PBS, lysed, and the protein content was determined by the Lowry method. Absorption of substrate solution was immediately measured at 405 nm against the substrate solution as blank. ATA activity was calculated as described and is expressed in ju,U/mg cellular protein [22] ,
Western blotting
A total of 107 quiescent cells of the various clones were washed in ice-cold PBS and scraped off the culture flask in disruption buffer (2% SDS, 60 mM Tris-HCl, pH 6.8; 100 mM dithiothreitol, 0.5% aprotinin, and 0.5 mM PMSF). Protein concentrations were adjusted to 100 ¡¿g/sample, 5% glycerol/0.03% bromophenol blue were added, and samples were boiled for 10 minutes. After centrifugation, supernatants were loaded onto a denaturing 8% SDS-polyacrylamide gel. Molecular weight markers (High molec ular Rainbow markers, Amersham) that comprise 14,300 to 200,000 Daltons served as molecular weight standards. After completion of electrophoresis, proteins were electroblotted onto a nitrocellulose membrane (Highbond-N; Amersham) in transfer buffer (50 mM Tris-HCl, pH 7.0; 380 mM glycine, 0.1% SDS, 20% methanol). Membranes were blocked for one hour at 22°C with 5% nonfat dry milk redissolved in PBS with 0.1% Tween 20. For the detection of ATA, a 1:500 dilution of the rat monoclonal antibody ASD-4 generated against mouse ATA was used as a primary antibody. The generation and characterization of this antibody has been previously described [23, 24] , A horseradish peroxidase-conjugated polyclonal rabbit anti-rat antibody (Sigma) was used as a secondary antibody. The ECL reagent (Amersham) was applied according to the recommendations of the manufac turer to visualize peroxidase. Western blots were repeated twice.
Immunofluorescence
Cells were grown in glass slide chambers (Nunc, Roskilde, Denmark) to subconfluence. Cells were then fixed at -20°C in acetone for 10 minutes before their staining. Slides were incu bated with a 1:20 dilution of the monoclonal ASD-4 antibody for one hour in a wet chamber. After washing in PBS with 0.5% albumin, the stain was developed with a 1:50 diluted FITC-labeled rabbit anti-rat IgG antiserum (Miles Scientific, Munich, Germa ny).
Intracellular inositol trisphophate concentrations
ATA5, ATA21 and Neo3 cells (2 X 105) were plated into six-well plates, rested for 24 hours in serum-free medium, and subsequently stimulated for 10 minutes with 10" 6 m Ang II. In addition, to inhibit ATA enzyme activity in ATA21cells, 20 jxl of ascites of the monoclonal anti-murine ATA antibody ASD-4 were added per well 30 minutes prior to challenge with control medium or Ang II. This antibody has been previously shown to inhibit ATA enzyme activity [23, 24] . Some ATA21 cells were also treated with 10 m of angiotensin III (Ang III; Sigma). The incubation was terminated with 15% trichloracetic acid, and supernatants of lysed cells were extracted three times with 10 vol water-saturated diethyl ether and then titrated to pH 7.5 with 1 u NaHC03. Cells were counted in parallel wells. Intracellular inositol 1,4,5-trisphosphate (IP3) was measured in duplicate from each experiment (N = 4 to 5 independent experiments) directly in the neutralized supernatants with a commercial radioimmunoas say according to the manufacturer's recommendations (Biotrak" from Amersham). Data are expressed as picomoles of IP3 per 105 cells.
Cellular proliferation
A total of 104 cells of the various lines were transferred to each well of a 96-well plate and were made quiescent in DMEM without PCS and G418. Cells were then incubated for 24 hours with a single dose of I0-s to 10 _ 6 m Ang II. This dose was shown earlier to be mitogenic for MMCs [J1,12] . To test for the effect of ATA expression, enzyme activity was inhibited for some experi ments with 0.1 mM amastatin. In order to inhibit ATA more specifically, ATA5 and ATA21 cells were incubated in the pres ence of 2 ¿¿I per well (96-well plate) of ascites of the monoclonal anti-murine ATA antibody ASD-4. For these experiments, cells incubated in control medium without Ang II also received the same amount of antibody to control for nonspecific effects. Additional cells received DMEM with either 2% or 10% FCS. Moreover, all cell lines were also treated with a single dose of either Ang III or angiotensin IV (Ang ll-(3-8) = Ang IV; Sigma). Cells were pulsed with 1 fiCi per well [3H]thymidine (5 Ci/mmol, Amersham) for the last six hours of culture. At the end of the incubation, cells were washed once in PBS, trypsinized for 10 minutes at 37°C, and finally collected on glass-fiber paper with an automatic cell harvester. Radioactivity of dry filters was deter mined by liquid scintillation spectroscopy in the presence of scintillation cocktail (Roth, Karlsruhe, Germany). [3H] thymidine incorporation experiments were independently repeated five to six times in duplicate. For direct cell counts, 105 cells were trans ferred into each well of a 24-well plate, rested for 24 hours in serum-free DMEM without G418, and stimulated for another 48 hours with 10 7 to 1 0 '6 m Ang II. At the end of the incubation period, cells were trypsinized, and counted in a Neubauer cham ber by an investigator blinded to the protocol. Direct ceil count experiments were independently repeated six times in duplicate.
Statistical analysis
All data are presented as the means ± sem. Statistical signifi cance between different groups was first tested with the nonparametric Kruskal-Wallis test. Individual groups were subse quently tested using the Wilcoxon-Mann-Whitney test. A P value of < 0.05 was considered significant.
RESULTS
Establishment and characterization of aminopeptidase A overexpressing mesangial cells
A total of twenty surviving G418 clones were screened by RT-PCR two weeks after transfection. From these clones, seven showed an amplification product of the expected 563 base pairs. Figure 1 shows an example of a cDNA amplification after reverse [3H] thymidine incorporation into DNA as one measurement of proliferation. Cells were incubated for 24 hours with a single dose of 10~8 to 10' 6 m Ang II in the absence of other factors. As predicted from earlier experiments [11] , Ang II stimulated proliferation in MMCs (□ ) and mock-transfected Neo3 cells (□). However, the vasoactive peptide failed to induce mitogenesis in ATA5 (E3) and ATA21 (■) cells. There was even a tendency in ATA5 cells that ANG II may cause inhibition of proliferation, although the values did not reach statistical significance. N = 10, *P < 0.05 versus unstimulated controls. antagonize Ang IPs effects. However, the currently employed drugs to intervene with the RAS may have some disadvantages. For example, it remains unclear whether ACE inhibitors in the commonly used dosage totally inhibit local tissue ACE activity [2] [3] [4] . In addition, ACE may be bypassed and active Ang IT can be formed by other enzymes such a chymase [47] . On the other hand, blockade of the AT j-receptor may shift binding of Ang II to other Abbreviations are: Ang, angiotensin; moAb, neutralizing anti-ATA monoclonal antibody. a P < 0.05 versus Ang II only receptors including AT2 [48] . Although this effect could be protective since AT2-receptor activation has been associated with antigrowth effects in some tissue [49, 50] , there is little evidence of this mechanism in renal tissue. Furthermore, we have recently provided evidence that stimulation of AT2-receptors in glomeru lar endothelial cells induces the synthesis of the chemokine RANTES, a strong chemoattractant substance for macrophages/ monocytes [51] . Treatment with ACE inhibitors as well as with ATr receptor antagonists stimulates renin synthesis. Recent evi dence suggests that renin directly binds to mesangial cells, stim ulates proliferation, and increases plasminogen activator inhibi tor-1 antigen, which are undesired effects that may occur during hyperreninemia [52] . Thus, overexpression of ATA spatially ad jacent to Ang II-receptors may locally inactivate Ang II without influencing RAS, providing some advantages over other therapeu tic manipulations. However, since Ang III, the product of ATAmediated Ang II metabolism, may also bind to AT,-receptors, ATA over expression in vivo would be only successful if Ang III is directly further cleaved to inactive fragments. In addition, we have overexpressed ATA in SV 40-transformed mesangial cells and it is currently unclear if this enzyme could be adequately overex pressed in normal mesangial cells residing in the glomerular microenvironment. Therefore, it remains to be established whether ATA-overexpression may be effective in vivo.
In summary, overexpressing of ATA in mesangial cells abol ished the proliferative effects of Ang II on these cells. Our experiments are a first step toward the development of novel strategies to selectively interfere with a locally activated RAS.
